Product Information

PREGABALIN 300 MG CAPSULE is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0644 per EA under NDC 69367043105. Its NADAC has been published 30 times since Jan 28, 2026.

FDA first approved this application on Mar 8, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 300 MG CAPSULE

Pregabalin
$0.0644per EA
DEA Schedule CV

Strength

300 mg/1

NDC

69367043105

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA212988

FDA Approved

3/8/2022

TE Code

AB

On Market Since

11/17/2025

Price Statistics

The NADAC for PREGABALIN 300 MG CAPSULE has been published 30 times since Jan 28, 2026, and over the history we have for it it has declined 4.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0644 per EA
All-time high$0.0673 (Feb 11, 2026)
All-time low$0.0644 (Aug 19, 2026)
52-week high$0.0673
52-week low$0.0644
Median price$0.0658
Average price$0.0658
Largest weekly change-2.3% (Mar 18, 2026)
Weeks tracked30
Tracking sinceJan 28, 2026

Price History

1W

-0.2%

1M

-2.2%

3M

-1.3%

6M

-3.8%

1Y

N/A

3Y

N/A

5Y

N/A

All

-4.3%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of PREGABALIN 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 300 MG CAPSULE, manufactured by Westminster Pharmaceuticals LLC, is $0.0644 per EA (NDC 69367043105), effective Aug 19, 2026.

How has the price of PREGABALIN 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 300 MG CAPSULE has declined 4.3%. It has been tracked across 30 weekly CMS publications since Jan 28, 2026.

What are the highest and lowest recorded NADAC prices for PREGABALIN 300 MG CAPSULE?

Since Jan 28, 2026, the NADAC for PREGABALIN 300 MG CAPSULE has ranged from a low of $0.0644 (Aug 19, 2026) to a high of $0.0673 (Feb 11, 2026), with a median of $0.0658 per EA.

Are there cheaper alternatives to PREGABALIN 300 MG CAPSULE?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PREGABALIN 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures PREGABALIN 300 MG CAPSULE?

PREGABALIN 300 MG CAPSULE (NDC 69367043105) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.